NCT07419191

Brief Summary

The aim of this study is to evaluate the role of endoscopic ultrasound (EUS) in the diagnosis of mediastinal and gastrointestinal subepithelial lesions. The study also aims to assess the diagnostic accuracy of endoscopic ultrasound (EUS) elastography in differentiating benign from malignant mediastinal and gastrointestinal subepithelial lesions.

Trial Health

63
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
35

participants targeted

Target at P25-P50 for all trials

Timeline
20mo left

Started Feb 2026

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress13%
Feb 2026Dec 2027

First Submitted

Initial submission to the registry

February 4, 2026

Completed
4 days until next milestone

Study Start

First participant enrolled

February 8, 2026

Completed
10 days until next milestone

First Posted

Study publicly available on registry

February 18, 2026

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 30, 2027

Expected
9 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2027

Last Updated

February 18, 2026

Status Verified

February 1, 2026

Enrollment Period

1.1 years

First QC Date

February 4, 2026

Last Update Submit

February 16, 2026

Conditions

Outcome Measures

Primary Outcomes (1)

  • Diagnostic yield of endoscopic ultrasound in mediastinal lesions and gastrointestinal subepithelial lesions

    Diagnostic yield will be defined as the proportion of participants in whom endoscopic ultrasound provides a definitive diagnosis confirmed by histopathological examination obtained through fine-needle aspiration, fine-needle biopsy, or surgical specimens

    At time of diagnostic procedure and after histopathological confirmation (within 2 weeks)

Secondary Outcomes (1)

  • Diagnostic accuracy of endoscopic ultrasound elastography for differentiating benign from malignant mediastinal and gastrointestinal subepithelial lesions

    During diagnostic procedure and after histopathological confirmation (within 2 weeks)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients referred for diagnostic EUS of a 1\_mediastinal mass or mediastinal lymphadenopathy detected on prior imaging (CT/MRI) . 2- subepithelial lesions lesion detected by endoscopy .

You may qualify if:

  • Age: Adults ≥ 12 years.
  • Clinical indication: Patients referred for diagnostic EUS of a 1\_mediastinal mass or mediastinal lymphadenopathy detected on prior imaging (CT/MRI) .
  • subepithelial lesions lesion detected by endoscopy .
  • Lesion accessibility: Lesion judged by the endosonographer to be accessible to EUS imaging and elastography and amenable to EUS-guided sampling

You may not qualify if:

  • patient Refusal or inability to provide informed consent
  • Uncorrectable coagulation disorder
  • Presence of contraindicating endoscopy/sedation
  • Lesion inaccessible to EUS or elastography (e.g., too far from the esophagus/airway to obtain reliable elastography or visualization) as judged by the performing endosonographer.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine

Asyut, Asyut Governorate, 10001, Egypt

Location

Related Publications (9)

  • Liu T, Al-Kzayer LFY, Xie X, Fan H, Sarsam SN, Nakazawa Y, Chen L. Mediastinal lesions across the age spectrum: a clinicopathological comparison between pediatric and adult patients. Oncotarget. 2017 Apr 18;8(35):59845-59853. doi: 10.18632/oncotarget.17201. eCollection 2017 Aug 29.

    PMID: 28938687BACKGROUND
  • Verma A, Jeon K, Koh WJ, Suh GY, Chung MP, Kim H, Kwon OJ, Um SW. Endobronchial ultrasound-guided transbronchial needle aspiration for the diagnosis of central lung parenchymal lesions. Yonsei Med J. 2013 May 1;54(3):672-8. doi: 10.3349/ymj.2013.54.3.672.

  • Varanese M, Spadaccini M, Facciorusso A, Franchellucci G, Colombo M, Andreozzi M, Ramai D, Massimi D, De Sire R, Alfarone L, Capogreco A, Maselli R, Hassan C, Fugazza A, Repici A, Carrara S. Endoscopic Ultrasound and Gastric Sub-Epithelial Lesions: Ultrasonographic Features, Tissue Acquisition Strategies, and Therapeutic Management. Medicina (Kaunas). 2024 Oct 15;60(10):1695. doi: 10.3390/medicina60101695.

  • Takeda S, Miyoshi S, Akashi A, Ohta M, Minami M, Okumura M, Masaoka A, Matsuda H. Clinical spectrum of primary mediastinal tumors: a comparison of adult and pediatric populations at a single Japanese institution. J Surg Oncol. 2003 May;83(1):24-30. doi: 10.1002/jso.10231.

  • Schofield PF, Hulton NR, Baildam AD. Is it acute cholecystitis? Ann R Coll Surg Engl. 1986 Jan;68(1):14-6.

  • Lardinois D, Weder W, Hany TF, Kamel EM, Korom S, Seifert B, von Schulthess GK, Steinert HC. Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography. N Engl J Med. 2003 Jun 19;348(25):2500-7. doi: 10.1056/NEJMoa022136.

  • Detterbeck FC, Lewis SZ, Diekemper R, Addrizzo-Harris D, Alberts WM. Executive Summary: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest. 2013 May;143(5 Suppl):7S-37S. doi: 10.1378/chest.12-2377. No abstract available.

  • Carder C, Fielding P, Roberts A, Foley K. Discordant nodal staging identifies intermediate-risk group for overall survival in patients with cT3 oesophageal adenocarcinoma. Eur Radiol. 2020 Jun;30(6):3429-3437. doi: 10.1007/s00330-019-06642-6. Epub 2020 Feb 13.

  • Annema JT, Versteegh MI, Veselic M, Welker L, Mauad T, Sont JK, Willems LN, Rabe KF. Endoscopic ultrasound added to mediastinoscopy for preoperative staging of patients with lung cancer. JAMA. 2005 Aug 24;294(8):931-6. doi: 10.1001/jama.294.8.931.

Related Links

Study Officials

  • Madiha Mohamed El Attar, professor

    Assiut University

    STUDY DIRECTOR
  • Haidi KaramAllah Ramadan, Professor

    Assiut University

    STUDY DIRECTOR
  • Mohamed Abdelghani Soliman, lecturer

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Abanoub Ayoub Melk, assistant lecturer

CONTACT

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
assistant lecturer

Study Record Dates

First Submitted

February 4, 2026

First Posted

February 18, 2026

Study Start

February 8, 2026

Primary Completion (Estimated)

March 30, 2027

Study Completion (Estimated)

December 30, 2027

Last Updated

February 18, 2026

Record last verified: 2026-02

Locations